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The conversion of basal keratinocytes to spinous and
granular cells is accompanied by the synthesis of a
series of epidermal proteins in a differentiation-specific
pattern. The transcription of several of these epidermal
marker genes is regulated by activator protein 1 (AP1)
interactions at their promoter regions. In the epidermis
the various AP1 transcription factors are not present
uniformly but appear to have a differentiation-specific
distribution. We have explored whether the AP1
regulated expression of the keratin 5, transglutaminase
1, involucrin, and loricrin genes reflects the distribution
of the AP1 factors in the epidermis. We have found
that c-jun and junD activate and junB downregulates
The process of terminal differentiation in the epidermisbegins when the mitotically active keratinocytes ceaseto proliferate and move out of the basal compartment.Progressively differentiating, they migrate through thespinous and granular layers to the cornified layers of the
epidermis (Watt, 1989; Fuchs, 1990; Fuchs and Byrne, 1994).
Each stage of differentiation is characterized by the expression of
marker genes. The transition from the basal to the spinous layer is
accompanied by the replacement of the keratin intermediate filament
proteins that are characteristic for proliferating epidermal keratinocytes,
keratins K5 and K14, with the suprabasal-specific keratins K1 and
K10 (Roop et al, 1988; Fuchs, 1990). Later the cells in the upper
spinous layer begin to synthesize a new structural protein, involucrin.
The transcription of keratins K1 and K10 is suppressed coincident with
the appearance of the late differentiation markers profilaggrin and
loricrin (Resing and Dale, 1991). The final product of the terminal
differentiation program is the anucleated cell consisting largely of
keratin intermediate filaments embedded in a filaggrin matrix. This is
contained within and protected by an insoluble cell envelope, a
15 nm thick layer of various proteins cross-linked by the action of
transglutaminase 1 (TGase 1) and transglutaminase 3 (TGase 3)
(Reichert et al, 1993).
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the transcription of both basal and suprabasal genes.
The effect of c-jun is exerted through interactions with
c-fos at the AP1 motifs in the target promoters,
whereas both junB and junD act independently of the
binding at the AP1 sites. Thus c-jun and junD act as
general positive regulators whereas junB acts as a general
suppressor of epidermal-specific genes. Therefore, the
differentiation specificity of the AP1 regulation must
be determined not only by the formation of distinct
DNA/AP1 complexes but also by interactions involving
other transcriptional regulators and/or distal regulatory
elements. Key words: differentiation/gene transcription.
J Invest Dermatol 110:34–40, 1998
The regulation of epidermal gene expression is controlled primarily
by transcriptional events. Several studies in recent years have established
a key role in these processes for activator protein 1 (AP1) proteins
(Takahashi and Iizuka, 1992; Liew and Yamanishi, 1992; Bernerd et al,
1993; Blumenberg, 1993; Saunders et al, 1993; Casatorres et al, 1994;
Hu and Gudas, 1994; Lu et al, 1994; Yamada et al, 1994; DiSepio et al,
1995; Navarro et al, 1995; Welter et al, 1995; Jang et al, 1996; Lopez-
Bayghen et al, 1996). AP1 consists of heterodimers between members
of the jun (c-jun, junB, and junD) and the fos (c-fos, fosB, fra1, and
fra2) families of transcription factors, and of homodimers between
different jun proteins (Angel and Karin, 1991). They modulate transcrip-
tion by binding to AP1 recognition motifs in the regulatory regions
of the target genes. The transcription of genes expressed in different
epidermal layers has been found to be AP1 dependent. These findings
suggested a differential role for AP1 proteins in the differentiation-
specific transcription in keratinocytes; however, the expression pattern
of the individual AP1 proteins in the epidermis and in the cultured
epidermal cells is still unclear. Although several laboratories have
reported a differentiation and temporal specificity in the distribution
of the AP1 factors, the results from the different studies are not
consistent and obviously depend on the experimental procedures. In
human skin c-jun expression has been detected predominantly to the
granular layer, junB, fosB, and fra2 are restricted to the basal and
spinous layers, fra1 is present in the spinous and granular cells, and
junD is expressed throughout the epidermal layers (Briata et al, 1993;
Basset-Seguin et al, 1994; Gandarillas and Watt, 1995; Welter and
Eckert, 1995). The distribution pattern of c-fos is unclear. Welter et al
(1995) localized the protein predominantly in the granular layer. Briata
et al (1993) reported equally distributed low levels of c-fos throughout
the epidermis. Basset-Seguin et al (1990, 1994) localized c-jun and c-
fos transcripts predominantly in basal and lower spinous cells, but
reported decreased levels of c-jun and c-fos in hyperproliferative
psoriatic epidermis, suggesting a role for them in epidermal differenti-
ation (Basset-Seguin et al, 1991). Reconstituted epidermis, nondifferen-
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tiated keratinocytes, and keratinocytes induced to differentiate by agents
decreasing the intracellular cAMP content, express equivalent levels of
c-jun and c-fos. When grafted on athymic mice, the reconstituted
epidermis shows predominant expression of c-jun in the granular layer,
whereas low c-fos expression is maintained throughout the layers
(Briata et al, 1993). Normal human epidermal keratinocyte (NHEK)
cells induced to terminal differentiation by disaggregation express low
but increasing amounts of c-jun, apparently constitutive amounts of
junD, and high amounts of junB, fra1, and fra2 in the latest stages of
differentiation, whereas c-fos expression is induced only in the early
stages (Gandarillas and Watt, 1995).
We hypothesized that dimers consisting of different jun and fos
members may participate in the strata specific regulation of the AP1-
responsive genes in the epidermal keratinocytes and that the activation
of transcription of the later markers follows the changes in the AP1
composition throughout the epidermal layers (Jang et al, 1996). To test
this hypothesis, we explored the role of individual AP1 members for the
function of the basal cell-specific K5, spinous cell-specific involucrin,
granular layer-specific loricrin, and the less restricted transglutaminase
I gene (TGM1) promoter, which is active throughout the epidermal
layers (Steinert et al, 1996). Our data indicate that in cultured human
epidermal keratinocytes, c-jun/c-fos heterodimers transactivate gene
expression independently of the status of differentiation through binding
at AP1 motifs that are indispensable for the activity of the regulatory
regions. Similarly, junB represses and junD activates transcription of
both basal and suprabasal genes. In contrast to c-jun, however, this
transregulation does not involve c-fos and does not depend on
interactions at the respective AP1 sites. We suggest that the differenti-
ation specificity of the AP1 effect is likely to be mediated by interactions
between both AP1 and other transcriptional regulators.
MATERIALS AND METHODS
Plasmid constructions A total of 2.5 kb of upstream regulatory sequence
of involucrin were amplified by polymerase chain reaction (PCR) using human
genomic DNA as a template and the following primers (HindIII and SalI
restriction sites used for cloning are shown in lower case): forward
–2473/–2453 aagcttCTTCTCCATGTGTCATGGGAT; reverse –13/19
gtcgacCACTTACCAGACT-CACAGTAAG. The PCR product was gel
purified, digested, and subcloned into the HindIII/SalI sites of pCAT-Basic
vector (Promega, Madison, WI). To introduce mutations in the AP1–1 and/
or AP1–5 the procedure of Welter et al (1995) was followed. Human TGM 1
sequences were amplified from genomic DNA with the following primers:
forward (–483/463) ctgcagCTGGTGGAGCCAGTCT-GAGGG; reverse
(–14/19) tctagaGCAGGACAGACCTGGTAAGTGAC. The PCR product
was gel purified, digested, and subcloned into the PstI/XbaI sites of pCAT-
Basic vector to generate TGM1-pCAT. Loricrin sequences were amplified by
PCR using a human loricrin genomic clone (Yoneda et al, 1992) and the
following primers (PstI and XbaI restriction sites used for cloning are shown
in lower case): forward (–1329/–1305) ctgcagCTGTCATTTCAAAACA-
TAACTGGGC; reverse (–12/19) tctagaAGA-TGCTGGCAATGTGAGGAC.
The PCR product was digested with BspHI, blunt ended, digested with XbaI,
and the resulting fragment spanning the region –154/19 of the loricrin
promoter was ligated into pCAT-Basic vector. To mutate the AP1 site of both
loricrin constructs, a PstI/SacI fragment of loricrin-pCAT was amplified by
PCR using the aforementioned loricrin forward primer and the following
reverse primer including the mutated AP1 site (SacI site used for cloning is
shown in lower case, AP1 mutation is underlined): gagctcTCC-
CTGACAAATTGATCCAGGCCAG. The PCR product was used to replace
the wild-type sequence in both loricrin-pCAT constructs. To mutate the AP1
site in the TGM1 construct, a PstI/XbaI fragment of TGM1-pCAT was
amplified by PCR using the aforementioned TGM1 forward primer and the
following reverse primer including the mutated AP1 site (XbaI site used for
cloning is shown in lower case, the AP1 mutation is underlined):
tctagaGCAGGACAGACCTGGTAAGTTTTTTATGTAGGG. The resulting
product was ligated into PstI/XbaI digested pCAT-Basic vector. K5 promoter
constructs were generated by PCR using human genomic DNA as a template
and the following primers (XbaI, SphI, and HindIII sites used for cloning are
shown in lower case; the AP1 mutations are underlined): forward wild-type
primer (–100/–67) CCCAGgcatgcCCAGCCCACTTAATCATCACAGC; for-
ward mutant primer (–100/–67) CCCAGgcatgcCCAGCCCACTTTATTAT-
CACAGC; forward wild-type primer (–750/–721) aagcttGGGCAGAAA-
AAATGCTGAGTTAGGAGGAGC; forward mutant primer (–750/–721)
aagcttGGGCAGAAAAAATGCTTTGTTAGG-AGGAGC; reverse primer
(132/111) tgtagaGAGCTCAGCAGGACGCAGAAGG. The products were
gel purified, digested, and ligated into SphI/XbaI-digested pCAT-Basic to
generate construct –100/132, or into HindIII/XbaI-digested pCAT-Basic for
construct –750/132. The nucleotide sequences of all constructs were verified
by dideoxynucleotide chain termination sequencing with a Sequenase kit
2.0 (USB, Cleveland, OH).
Cell cultures, transfections, and protein assays Cryopreserved NHEK
were obtained from Clonetics (San Diego, CA) and grown in calf skin collagen
(Sigma, St. Louis, MO) coated dishes in serum free keratinocyte growth
medium (Clonetics) at 0.05 mM Ca21, supplemented with 60 µg bovine
pituitary extract per ml. Third passage NHEK cells were used for transfection
and preparation of nuclear extracts. F9 and HeLa cells were purchased from
the American Tissue Culture Collection (ATCC, Rockville, MD) and were
grown and maintained following the recommended procedures. Transient
transfections were performed in duplicate using Lipofectin reagent (Life Techno-
logies, Bethesda, MD) following the manufacturer’s instructions. Typically 2–
3.5 3 105 cells were plated in 6-well culture plates 24 h before transfection.
Transfection was performed as described (Jang et al, 1996) when cultures reached
60–70% confluence. Typically, 1 µg of the reporter DNA and 0.5 µg of the
expression vector DNA per well were used. Transfection efficiency was
monitored by use of 0.5 µg thymidine kinase β-galactosidase (β-gal) construct
(Clontech, Palo Alto, CA). After transfection the medium was replaced with
medium in which the cells normally grow and for NHEK the Ca21 in the
keratinocyte growth medium was adjusted to 0.05 or 1.2 mM. Cells were
harvested 48 h after transfection, and the chloramphenicol acetyl transferase
(CAT) and β-gal activity were assayed as described (Lee et al, 1996). The values
for CAT were normalized by β-gal activity and protein content. The relative
CAT values are the average 6 SD of at least three independent experiments,
each performed in duplicate.
Nuclear extracts and mobility shift assay Nuclear extracts were prepared
according to Schreiber et al (1989) with the modifications reported in Lee
et al (1996).
Mobility shift experiments were performed as described (Lee et al, 1996).
The supershift experiments used commercially available antibodies specific for
the individual AP1 proteins (Santa Cruz Biotechnology, Santa Cruz, CA) and
are described in Jang et al (1996). The sequences of the oligonucleotides are
shown above the corresponding bandshift profiles.
RESULTS
The activity of K5 and TGM1 promoters is under the control
of AP1 elements To compare the role of AP1 factors for the
function of promoters that are normally active at various stages of the
epidermal differentiation, we needed to functionally define the so far
uncharacterized AP1 recognition motifs in the K5 and TGM1 genes.
We compared the sequences of K5 and TGM1 59-flanking regions
with the known AP1 recognition motifs (Faisst and Meyer, 1992).
The human K5 promoter has a putative AP1 motif at position
–735 (site E in Ohtsuki et al, 1992) and another at position –79. The
AP1 element known to be present within 820 bp of the 59-flanking
region that renders the TGM1 promoter phorbol ester-responsive
(Yamada et al, 1994), was found in close vicinity to the TGM1
transcription initiation site at position –15.
To find out whether these AP1 motifs were indeed involved in the
regulation of the respective genes, K5 sequences –750 to 132 and
–100 to 132, and TGM1 sequences between –483 and 19, were
tested for their ability to drive expression of a promoterless CAT
reporter construct in NHEK cells. The K5 59-flanking region was
transcriptionally active and mutations of the AP1 site at position –79
reduced the activity of the reporter constructs –750/132 and –100/
132 by 50 and 75%, respectively (Fig 1). Mutation of the AP1 site
at position –735 did not change the level of expression (data not
shown). The expression from TGM1 construct –483/19 was 85 times
higher than that of the promoterless pCAT-Basic vector itself. The
AP1 motif at position –15 was essential for this activity, because a
mutation in this sequence reduced the expression by more than
75% (Fig 1).
The AP1 motifs in the epidermal gene promoters are recognized
by AP1 proteins in the keratinocyte nuclear extracts To investi-
gate whether the newly defined AP1 sites of the K5 and the TGM1
promoters were recognized by nuclear proteins in the human ker-
atinocytes, 59-labeled double-stranded probes encompassing the
respective sites were combined with NHEK nuclear extracts, and
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Figure 1. Transient expression of the CAT-reporter gene under the
control of K5 and TGM1 59-upstream sequences. Fragments spanning the
designated lengths of the K5 and TGM1 59-flanking regions were subcloned
into the promoterless pCAT-Basic reporter vector carrying the chloramphenicol
acetyl transferase gene CAT. The positions and the sequences of the wild-type
and the mutant AP1 motifs are shown. NHEK cells were transfected and the
activity of CAT was determined. The values for CAT were normalized by
protein content and β-gal activity of the cotransfected vector pTKβ. They are the
average of at least three independent experiments, each with duplicate samples.
Figure 2. Bandshift analysis. The sequences of the wild-type (P) and the
mutant variants of the AP1 motifs used in the binding reactions are shown
above the bandshift profiles for K5 (a), TGM1 (b), involucrin (c), and loricrin
(d). Five micrograms of NHEK nuclear extract was combined with 2–4 3 104
cpm of the 59-end-labeled double-stranded oligonucleotide under the conditions
described in Materials and Methods. The DNA-protein complexes were resolved
on 6% polyacrylamide gels in 0.5 3 TBE buffer. Lanes 1, binding profile of the
wild-type oligonucleotides P with NHEK extract; lanes 2, competition of the
binding with a 100-fold molar excess of unlabeled P; lanes 3, mutant AP1
oligonucleotides; lanes 4, consensus AP1 oligonucleotide bearing the sequence
TGAGTCA.
nucleoprotein complexes were detected that migrated slower than the
probe itself (Fig 2a,b, lanes 1). The bands marked with an arrowhead
disappeared upon self-competition (lanes 2) and when a 100-fold molar
excess of an AP1 consensus oligonucleotide was added (lanes 4), but their
intensity was much less affected when corresponding oligonucleotides
Figure 3. Supershift analysis. Constructs were of involucrin AP1–5 (a) and
loricrin AP1 (b) DNA/protein complexes with anti-human IgG (lanes 1) and
with antibodies specific for c-jun (lanes 2), junB (lanes 3), junD (lanes 4), c-fos
(lanes 5), fra1 (lanes 6), and fra2 (lanes 7). The arrowheads on the right point to
positions of the supershifted complexes.
carrying mutations in the AP1 sequences (lanes 3) or poly(dI-dC) (data
not shown) were added.
The bandshift profiles were compared with those already published
for the functional AP1 sites AP1–1 and AP1–5 of involucrin gene
(Welter et al, 1995) (Fig 2c), and with the bandshift profile of the AP1
site at position –54 of the human loricrin gene (Fig 2d). The loricrin
AP1 motif was investigated because it is conserved between the human
and the mouse genes and has been shown to be essential for the activity
of the mouse loricrin promoter (DiSepio et al, 1995). The bandshift
profiles clearly show that the double-stranded oligonucleotides tested
contain AP1 recognition motifs that are recognized by proteins in the
keratinocyte nuclear extracts.
The composition of the AP1 complexes was investigated in supershift
experiments using antibodies specific for the individual jun and fos
proteins. We found that all AP1 complexes contained the three jun
proteins and c-fos, fra1, and fra2. We were not able to detect binding
to fosB. Examples showing the profiles with involucrin AP1–5 and
loricrin AP1 motifs are presented in Figs 3a and 3b, respectively.
Effect of c-jun and c-fos on the activity of the epidermal gene
promoters Because we detected complexes with all AP1 proteins,
we wanted to clarify whether a common mechanism underlies the
AP1 regulation of these epidermal genes. We investigated the influence
of c-jun, junB, junD, and c-fos transcription factors. The regions
–750/132 of K5 (Fig 4a), –483/19 of TGM1 (Fig 5a), 2473/19 of
involucrin (Fig 6a), and –154/19 of loricrin (Fig 7a) encompassing the
functional AP1 sites described above, together with their counterparts
carrying mutations in the respective AP1 motifs, were cloned upstream
of the promoterless CAT reporter gene. These constructs were cotrans-
fected into NHEK cells with vectors expressing c-fos, c-jun, c-
jun/TAM (a dominant negative mutant of c-jun with a truncated
transactivating domain), junB, or junD. The data in Figs 4–7 are for
1.2 mM Ca21 but very similar results were obtained in 0.05 mM Ca21
(data not shown).
As shown in Figs 4b–7b, forced expression of c-fos had very little
if any effect on the activity of all constructs, which is consistent with
the high levels of c-fos protein in cultured human keratinocytes (Basset-
Seguin et al, 1990, 1994; Briata et al, 1993), and with the incapacity
of c-fos alone to influence transcription. Co-transfection of c-jun
expression vector induced CAT activity from all four promoters.
Simultaneous cotransfection of c-fos and c-jun expression vectors
synergistically increased the level of CAT activity 2- to 3-fold for K5,
TGM1, and involucrin constructs, and 10-fold for loricrin. The
transactivation by c-jun alone or in combination with c-fos was
abolished by mutations in the AP1 sites in all four promoters (Figs 4b–
7b). Similarly, truncation of the transactivating domain of c-jun not
only prevented upregulation by c-jun/TAM, but also interfered with
the function of the endogenous c-jun and reduced the activity of all
four constructs several fold below the level of the reporter alone
(Figs 4b–7b, compare Control and TAM). Taken together, these data
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Figure 4. Effect of AP1 factors on the activity of the K5-pCAT
constructs. (a) K5-pCAT wild-type and mutant constructs; (b) 1.0 µg of the
corresponding K5-pCAT constructs were cotransfected into NHEK cells
together with 0.5 µg of plasmid DNA expressing c-fos, c-jun, TAM, junB, or
junD cDNA or with 0.5 µg of expression vector DNA only. The relative
values of the transient CAT activity are presented as a fold change over the
activity of K5-pCAT construct –750/132 (shown as Control), cotransfected
with the RSV expression vector for c-fos and c-jun, with the CMV expression
vector for TAM and jun B and with the SV40 expression vector for jun D,
respectively. (c) Effect of AP1 proteins in F9 cells under the conditions described
in (b).
indicate that not only are the AP1 motifs essential for the activity of
the corresponding promoters, but that the transactivation requires
interactions between these motifs and c-jun/c-fos heterodimers and
depends critically on the transactivating properties of c-jun. Thus, the
data suggest that the amount and/or activity of c-jun is a critical factor
in the AP1 controlled epidermal transcription.
junD activates and junB represses epidermal transcription inde-
pendently of the AP1 sites Forced expression of junD enhanced
transcription 1.5–5-fold from all wild-type constructs. Simultaneous
cotransfection of c-fos and junD was marginally more effective (Figs 4b–
7b); however, in contrast to c-jun, the effect did not require intact
AP1 sites, because the activity was equally increased when the AP1
sites were mutated.
Expression from epidermal promoter constructs was invariably
downregulated when junB expression vector was cotransfected
(Figs 4b–7b). In contrast to c-jun and similarly to junD, junB exerted
its effect via interactions that did not involve the AP1 sites, because
Figure 5. Effect of AP1 factors on the activity of the TGM1-pCAT
constructs. (a) Constructs used. Transfected into NHEK cells (b) or F9 cells
(c). The relative values of the transient CAT activity are presented as a fold
change over the activity of TGM1-pCAT construct –483/19 (shown as
Control), cotransfected with the RSV expression vector for c-fos and c-jun,
with the CMV expression vector for TAM and junB, and with the SV40
expression vector for junD, respectively.
wild-type and mutant constructs showed similar reduction in their
activity. Simultaneous cotransfection of junB and c-fos could not
change the transrepression exerted by junB alone (data not shown).
AP1 can activate epidermal promoters in nonepidermal
cells The correlation between AP1 and the transcriptional activity
of the epidermal promoters in NHEK cells prompted us to explore
whether AP1 activity may impart to other cell types the ability to
express epidermal genes. Mouse embryonic carcinoma F9 cells, which
do not transcribe any epidermal markers, were chosen because in the
undifferentiated state these cells do not contain c-fos, have a very low
level of c-jun and junB, and have a low constitutive expression of
junD (Yang-Yen et al, 1990). On their own, K5, TGM1, involucrin,
and loricrin promoters generated minimal CAT expression in F9 cells.
Both wild-type and mutant constructs showed a low constitutive
activity (Figs 4c–7c) that was 20–50% of the activity of a pCAT-
Promoter vector in which the CAT gene was regulated by the SV40
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Figure 6. Effect of AP1 factors on the activity of the involucrin-pCAT
constructs. (a) Constructs used. Transfected into NHEK cells (b) or F9 cells
(c). The relative values of the transient CAT activity are presented as a fold
change over the activity of involucrin-pCAT construct –2473/19 (shown as
Control), cotransfected with the RSV expression vector for c-fos and c-jun,
with the CMV expression vector for TAM and junB, and with the SV40
expression vector for junD, respectively.
early promoter (data not shown). Consistent with the data from the
NHEK cells, cotransfection with c-fos expression vector alone had no
effect on the level of expression; however, when the cells were
cotransfected with the c-jun expression vector and especially with c-
jun and c-fos together, a substantial increase in CAT activity was
detected (4- to 10-fold). The promoter activity remained low when
the AP1 sites were mutated or the c-jun/TAM transactivating mutant
was used (Figs 4c–7c). Co-transfection with junB had no effect on all
four promoters. An enhancement of CAT activity equal or greater to
that observed with c-jun was obtained upon cotransfection with junD.
No binding to the AP1 sites or heterodimerization with c-fos was
required for this effect (Figs 4c–7c).
To elucidate whether the effect of AP1 was specific for NHEK or
common to other epithelial cells, we performed the cotransfection
experiments in HeLa cells, which have acquired many characteristics of
simple epithelia. Again junB repressed and junD activated transcription
independently from the AP1 sites whereas interactions of c-jun/c-fos
heterodimers at the AP1 sites were responsible for strong enhancement
(data not shown). A major difference from NHEK cells was that in
HeLa cells the positive effect of c-jun did not depend on the
transactivating properties of c-jun. As found previously for the pro-
filaggrin promoter (Jang et al, 1996), cotransfection of the epidermal
constructs with c-jun/TAM did not interfere with the activity of
endogenous c-jun but rather led to increased levels of CAT (data not
shown). This suggests the mechanisms for AP1, and especially c-jun
transregulation, are different in NHEK and HeLa cells.
Figure 7. Effect of AP1 factors on the activity of the loricrin-pCAT
constructs. (a) Constructs used. Transfected into NHEK cells (b) or F9 cells
(c). The relative values of the transient CAT activity are presented as a fold
change over the activity of loricrin-pCAT construct –1329/19 (shown as
Control), cotransfected with the RSV expression vector for c-fos and c-jun,
with the CMV expression vector for TAM and junB, and with the SV40
expression vector for junD, respectively.
DISCUSSION
Essential role of AP1 for the activity of the epidermal
promoters Studies in recent years from different laboratories have
indicated that the transcriptional activity of epidermal genes, expressed
both in proliferating and in differentiating keratinocytes, require
interactions between AP1 recognition motifs and the cognate transcrip-
tion factors.
Our data demonstrate that providing the missing AP1 activity leads
to the activation of epidermal promoters in the nonpermissive F9 cells;
however, the F9 cells that were cotransfected with either c-jun or
junD were not able to express endogenous epidermal genes (data not
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shown). Furthermore, it is known that HeLa cells express high levels
of AP1 and yet they still do not transcribe epidermal markers.
Collectively, our results indicate that presence of AP1 is a necessary
but not sufficient factor in the multistage control of epidermal transcrip-
tion. The differences in the mechanisms through which AP1 proteins
affect transcription in HeLa and NHEK cells (Jang et al, 1996; this
paper) suggest that the cell-type specificity may be determined by the
composition of the AP1 complexes and their interactions with other
transcriptional regulators.
Expression of AP1 in epidermal strata and role of individual
AP1 members in epidermal gene transcription In view of these
findings, the question of the amount and the distribution of the AP1
proteins in mammalian epidermis and in cultured epidermal cells
becomes critically important; however, as already mentioned, the
current data do not allow unambiguous evaluation. The NHEK nuclear
extracts used in our study contained c-jun, junB, junD, c-fos, fra1,
and fra2 binding activity (Fig 3). The amounts of the proteins and the
DNA binding activity were not markedly affected by addition of
calcium to 1.2 mM (data not shown), conditions at which the levels
of expression of differentiation markers such as loricrin and profilaggrin
increased several-fold (Hohl et al, 1991; Jang et al, 1996).
Very little is known about which AP1 proteins are involved in the
regulation of gene transcription in human epidermal cells and how they
affect the differentiation specificity of expression. TGM1 expression has
been found to be activated by c-jun (Yamada et al, 1994). In bandshift
assays, Welter et al (1995) have detected strong binding of the involucrin
AP1 motifs to junB, junD, and fra1, but not to c-jun or c-fos. This
paper represents the first more detailed study of the role of AP1 in the
regulation of epidermal transcription in human keratinocytes. We show
that all AP1 sites investigated, including involucrin AP1 site 5 (Fig 6a)
and site 1 (not shown), interact with c-jun, junB, and junD and with
c-fos, fra1, and fra2. The weak intensity of the bands supershifted by
c-jun antibody (Fig 3) correlates well with the relatively low abundance
of c-jun transcripts in cultured keratinocytes (Gandarillas and Watt,
1995). All epidermal genes investigated are transactivated by c-jun and
junD and downregulated by junB. These effects were observed under
both low (0.05 mM) and high (1.2 mM) calcium concentrations and
were consistent with the unchanged status of AP1 activity under these
conditions (data not shown).
Specificity of AP1 regulation Our data indicate that the initial
concept that activation of different AP1 proteins determines the
activation of transcription of the epidermal markers in the different
strata (Jang et al, 1996; Eckert and Welter, 1996) is too simplistic. The
fact that all studied genes are transactivated by junD in various cell
types in an AP1-binding independent manner suggests a role for this
protein in the core constitutive activity of the epidermal promoters.
This is in good agreement with the expression of junD throughout all
epidermal layers (Welter et al, 1995) and in both differentiated and
nondifferentiated NHEK cells (Gandarillas and Watt, 1995). Similarly,
the repression that junB exerts on the activity of all five genes studied
appears to be constitutive rather than cell type- or differentiation-
specific. Again the abundance of junB in the lower epidermal layers
supports such an assumption.
All epidermal genes investigated are transactivated by c-jun/c-fos
heterodimers at the respective AP1 sites in the promoter regions and,
at least for the profilaggrin promoter, this effect is keratinocyte-specific
(Jang et al, 1996); however, the present data define c-jun not only as
a transactivator of genes whose expression coincides with the expression
of c-jun itself in the epidermis, but also as a general transactivator of
epidermal gene transcription, at least in NHEK cells. This is also in
good agreement with the data of Takahashi and Iizuka (1992) and of
Welter et al (1995) demonstrating that the activity of involucrin AP1
sites increases markedly upon treatment with 12-O-tetradecanoyl-
phorbol-13-acetate. Under these conditions, the amounts of c-jun and
c-fos proteins in NHEK cells also increase (data not shown).
Possible modulation of the AP1 effect in the epidermis The
regulatory activity of AP1 is affected by the status of phosphorylation
of the individual jun proteins (Woodgett et al, 1993). At least some of
them were localized in high amounts in the cytoplasm of the epidermal
cells (Briata et al, 1993; Welter et al, 1995). Therefore, changes in the
phosphorylation and translocation of the proteins in response to
extracellular signals may be involved in the fine tuning of the AP1-
regulated epidermal transcription. While faithfully operating in the
tissue, these mechanisms may be absent or not required in the
cultured cells.
The effect of the AP1-bound transcriptional regulators could be
modulated by interactions involving regions distal to the transcription
initiation site. It is possible that low amounts of c-jun in the basal and
spinous cells interact with the AP1 site(s) and are responsible for their
keratinocyte specificity. The extent to which these sites contribute to
the level of expression, however, might be determined by distal
sequences. Two lines of evidence support this idea. First, although the
activity of both K5 constructs –750/132 and –100/132 depended on
the AP1 site at position –79 (Fig 1), the activity of –750/132 in
1.2 mM Ca21 was twice lower than the activity in 0.05 mM Ca21
and the mutation in the AP1 site at position –79 not only reduced the
expression 2-fold but eliminated the calcium effect (data not shown).
Second, Byrne and Fuchs (1993) found that 90 bp upstream of the K5
mRNA start site (that encompass the AP1 site) confer significant levels
of keratinocyte-specific activity to a reporter gene in transgenic mice.
The expression of the transgene, however, was restricted to the
suprabasal layers rather than to the basal cells in which K5 is normally
expressed. Extension of the regulatory region 6 kb upstream was
necessary to restore the differentiation specificity. Thus it is conceivable
that distal interactions involving additional transcriptional regulators
may repress the c-jun dependent expression. An example for such
interactions involving AP1 and a silencer YY.1 activity was recently
reported in the involucrin 59-region (Lopez-Bayghen et al, 1996).
Different members of the jun family can interact among themselves
and are capable of structural and functional interactions with other
transcriptional regulators (Angel and Karin, 1991; Pfeuffer et al, 1994;
Thanos and Maniatis, 1995). Depending on the context of the 59-
flanking region, ets, NF-kB, and homeodomain-containing transcrip-
tion factors interfere with the effect of c-jun and 12-O-tetradecanoyl-
phorbol-13-acetate to both activate or repress the transcription from
the profilaggrin promoter (Jang S-I, Morasso MI, Andreoli JM, Steinert
PM, and Markova NG, unpublished observations). It is possible that
complexes formed between the jun proteins and the other members
of the fos family, fra1 and fra2, may also modulate the specificity of
the AP1 effect.
Therefore, while clearly implicating AP1 proteins as key regulators
of keratinocyte transcription, our data indicate that the proper spatial
and temporal expression of epidermal genes is determined by an
interplay of distinct AP1 complexes present in different cell types and by
their interactions with other transcriptional regulators. Differentiation-
specific knockout experiments may be required to clarify the effect of
the individual AP1 proteins in epidermis in vivo.
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